MWG Intrinsic Valuation and Fundamental Analysis - InMed Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 1.13 EUR -0.88% Market Closed

Market Cap: €18.4m

I	InMed Pharmaceuticals Inc F:MWG	CA
	Plexus Corp F:PX4	US
	Miller Industries Inc F:5OJ	US
	Intracom Holdings SA F:INTA	GR

Intrinsic Value

MWG price has not been updated for more than 4 months. This may indicate that the stock has been delisted.

MWG doesn't have a meaningful market cap.

Is MWG undervalued or overvalued?

See the intrinsic value estimate for InMed Pharmaceuticals Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

MWG Intrinsic Value

Unlock

Today vs. history

See how today’s valuation compares with MWG’s past valuations and how the stock performed after similar periods.

See what happened next Free account required

Track Buy Zone

20% below Intrinsic Value

Get notified when the price drops into your buy zone

Current Price €1.13

Intrinsic Value Locked

Margin of Safety 20% Locked

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Fundamental Analysis

What InMed Pharmaceuticals Does

Pharmaceuticals Health Care

InMed Pharmaceuticals, Inc. engages in developing small molecule drug candidates targeting the CB1/CB2 receptors. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2001-06-21. The firm develops a pipeline of small molecule drug candidates targeting the CB1/CB2 receptors. Its InMed Pharma segment is engaged in the research and development of small molecule pharmaceuticals drug candidates.

Headquarters: Canada CA
IPO date: Jun 21, 2001